Urinary volatile fingerprint based on mass spectrometry for the discrimination of patients with lung cancer and controls.

Profile signals of urine samples corresponding to patients with lung cancer and controls were obtained using a non-separative methodology. The method is based on the coupling of a headspace sampler, a programed temperature vaporizer and a mass spectrometer (HS-PTV-MS). With only a centrifugation step as prior sample treatment, the samples were subjected to the headspace generation process and the volatiles generated were introduced into the PTV where they were trapped in the Tenax® packed liner while the solvent was purged. Finally, the analytes were introduced directly, without separation, into the mass spectrometer which allows obtaining the fingerprint of the analyzed sample. The mass spectrum corresponding to the mass/charge ratios (m/z) ranging between 35 and 120amu (amu) contains the information related to the composition of the headspace and is used as the analytical signal for the characterization of the samples. Samples of 14 patients with some type of cancer and 24 healthy volunteers were analyzed and the profile signals were subjected to different chemometric techniques, including support vector machines (SVM), linear discriminant analysis (LDA) and partial least squares- discriminant analysis (PLS-DA), with the aim of differentiating the samples of patients with cancer from those of control. Values of 100% were obtained both in sensitivity and specificity in most cases. This methodology has been used previously, as described later, for the analysis of the fingerprint corresponding to saliva samples of patients and controls. However, up to date, the method has not been used in urine samples with the aim of fast discrimination between patients with cancer and controls. The advantages and disadvantages of using urine versus other types of matrices such as saliva are stated. In view of the results obtained in this work, the use of pattern recognition techniques with data corresponding to HS-PTV-MS profile signals is highly suitable as a first screening step to differentiate samples. In addition, it could be applied to a high number of samples in a relatively short period of time due to its high throughput.

[1]  Daniel Cozzolino,et al.  Classification of Tempranillo wines according to geographic origin: combination of mass spectrometry based electronic nose and chemometrics. , 2010, Analytica chimica acta.

[2]  J. P. Pavón,et al.  Headspace generation coupled to gas chromatography-mass spectrometry for the automated determination and quantification of endogenous compounds in urine. Aldehydes as possible markers of oxidative stress. , 2014, Journal of chromatography. A.

[3]  Phil A. Brown,et al.  Changes in urine headspace composition as an effect of strenuous walking , 2015, Metabolomics.

[4]  J. Kałużna-Czaplińska,et al.  Current applications of chromatographic methods for diagnosis and identification of potential biomarkers in cancer , 2014 .

[5]  A. Mazzatenta,et al.  Real time analysis of volatile organic compounds (VOCs) in centenarians , 2015, Respiratory Physiology & Neurobiology.

[6]  Q. Chu,et al.  Sensitive determination of endogenous hexanal and heptanal in urine by hollow-fiber liquid-phase microextraction prior to capillary electrophoresis with amperometric detection. , 2014, Talanta.

[7]  Ruth Etzioni,et al.  Early detection: The case for early detection , 2003, Nature Reviews Cancer.

[8]  B. Callejón-Leblic,et al.  Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform. , 2016, Journal of proteomics.

[9]  I. Horváth,et al.  Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.

[10]  J. Sung,et al.  Mass spectrometry-based electric nose system for assessing rice quality during storage at different temperatures , 2014 .

[11]  K. Markstaller,et al.  Ventilations-Perfusions-Verteilungen in der Lunge , 2007, Der Anaesthesist.

[12]  In situ identification of dimethyl diselenide in hepatocytes treated with methylseleninic acid by membrane inlet mass spectrometry , 2009 .

[13]  Leslie S. Ettre,et al.  Static Headspace-Gas Chromatography: Theory and Practice , 1995 .

[14]  Shiqiang Huang,et al.  A novel solid-phase microextraction method based on polymer monolith frit combining with high-performance liquid chromatography for determination of aldehydes in biological samples. , 2011, Analytica chimica acta.

[15]  José Luis Pérez Pavón,et al.  Headspace-programmed temperature vaporizer-mass spectrometry and pattern recognition techniques for the analysis of volatiles in saliva samples. , 2016 .

[16]  V. Moreno,et al.  Ion mobility and Top-down MS complementary approaches for the structural analysis of protein models bound to anticancer metallodrugs , 2014 .

[17]  José Luis Pérez Pavón,et al.  Strategies for qualitative and quantitative analyses with mass spectrometry-based electronic noses , 2006 .

[18]  A. Mazzatenta,et al.  Real-time breath analysis in type 2 diabetes patients during cognitive effort. , 2013, Advances in experimental medicine and biology.

[19]  J. P. Pavón,et al.  Headspace-programmed temperature vaporization-mass spectrometry for the rapid determination of possible volatile biomarkers of lung cancer in urine , 2016, Analytical and Bioanalytical Chemistry.

[20]  A. B. Robinson,et al.  Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Hanna,et al.  Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. , 2013, Analytical chemistry.

[22]  B. Buszewski,et al.  Analytical and unconventional methods of cancer detection using odor , 2012 .

[23]  T. Whitehouse,et al.  Volatile Biomarkers in Breath Associated With Liver Cirrhosis — Comparisons of Pre- and Post-liver Transplant Breath Samples , 2015, EBioMedicine.

[24]  Pedro A. Gómez,et al.  Sensitivity Enhancement in the Determination of Volatile Biomarkers in Saliva Using a Mass Spectrometry-Based Electronic Nose with a Programmed Temperature Vaporizer , 2014 .

[25]  José Luis Pérez Pavón,et al.  Use of mass spectrometry methods as a strategy for detection and determination of residual solvents in pharmaceutical products. , 2006 .

[26]  A. Mazzatenta,et al.  Pathologies currently identified by exhaled biomarkers , 2013, Respiratory Physiology & Neurobiology.

[27]  Marcus Wolff,et al.  VOC breath biomarkers in lung cancer. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[28]  G. Hanna,et al.  Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer. , 2013, Analytical chemistry.

[29]  J. P. Pavón,et al.  Fast analytical methodology based on mass spectrometry for the determination of volatile biomarkers in saliva. , 2012, Analytical chemistry.

[30]  A. Mazzatenta,et al.  Volatile organic compounds (VOCs) fingerprint of Alzheimer's disease , 2015, Respiratory Physiology & Neurobiology.